Related Experiment Video

Updated: Feb 24, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.6K

How can we improve medical adherence to intranasal corticosteroids in children?

Emre Ocak1, Deniz Kocaoz1, Baran Acar1

  • 1Department of Otorhinolaryngology, Kecioren Research and Training Hospital, Ankara, Turkey.

International Journal of Pediatric Otorhinolaryngology
|August 14, 2017
PubMed

Insights

Caregiver burden from multiple dependent children impacts adherence to intranasal corticosteroids (ICS) for allergic rhinitis (AR) in children. Addressing family factors is key for effective treatment plans.

Area of Science:

  • Pediatrics
  • Allergology
  • Pharmacology

Background:

  • Allergic rhinitis (AR) significantly impacts children's quality of life.
  • Intranasal corticosteroids (ICS) are a primary treatment for AR.
  • Understanding nonadherence factors is crucial for optimizing pediatric AR management.

Purpose of the Study:

  • To identify factors associated with nonadherence to intranasal corticosteroids (ICS) in pediatric allergic rhinitis (AR).
  • To evaluate the role of caregiver-related variables in treatment adherence.

Main Methods:

  • Prospective study involving 76 children diagnosed with AR.
  • Treatment with mometasone furoate nasal spray for 30 days.
  • Caregiver questionnaires and the validated Turkish Morisky Medical Adherence Scale (MMAS-8) were used.

Main Results:

  • The mean MMAS-8 score indicated generally good adherence (71.51%).
  • A higher number of dependent children per caregiver was the sole significant factor linked to lower adherence (p=0.011).

Conclusions:

  • Caregiver burden, specifically the number of dependent children, is a key factor in pediatric AR treatment nonadherence.
  • Clinicians should consider demographic and sociocultural factors, integrating treatment into daily routines.
  • Involving fathers in the treatment plan can provide additional support to mothers.
Abstract

Keywords:
AdherenceAllergic rhinitisChildrenCorticosteroidsIntranasal

More Related Videos

Intranasal Administration of CNS Therapeutics to Awake Mice07:15

Intranasal Administration of CNS Therapeutics to Awake Mice

Published on: April 8, 2013

62.0K
Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery05:44

Novel Methods for Intranasal Administration Under Inhalation Anesthesia to Evaluate Nose-to-Brain Drug Delivery

Published on: November 14, 2018

21.3K

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
889
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.7K
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
883
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
907
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K